 Connection
Carolina Schinke to Sulfonamides
This is a "connection" page, showing publications Carolina Schinke has written about Sulfonamides.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.201 |
|
|
|
-
Nalghranyan S, Singh AP, Schinke C. The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia. Am J Hematol. 2020 02; 95(2):E34-E35.
Score: 0.145
-
Rivera-Pe?a B, Chakraborty S, Shi Y, Zhang H, Desai SR, Patel PP, Sun Y, Zhao R, Choudhary G, Mitchell SG, Pradhan K, Zhang J, Zhang X, Fu B, Lopez R, To?ic I, Aluri S, Schinke C, Wysota M, King Z, Varshavsky A, Feld J, Carbajal M, Ramachandra N, Verma A, Goldfinger M, Sidoli S, Frank DA, Saunthararajah Y, Shastri A. Pyrimethamine overcomes resistance to hypomethylating agents by reducing de novo pyrimidine synthesis. Exp Hematol. 2026 Apr; 156:105382.
Score: 0.056
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|